Chimeric antigen receptor (CAR) T cell therapy has become a new mainstay in the treatment of several hematologic malignancies, but the spectrum of associated complications is still incompletely defined. Here, we report the case of a 70-year-old female patient treated with tisagenlecleucel for diffuse large B cell lymphoma (DLBCL), who developed chronic diarrhea with characteristics of inflammatory bowel disease (IBD)-like colitis. CAR T cells were substantially enriched in the colon lamina propria and other diagnoses were ruled out. Thus, we conclude that IBD-like colitis in this patient was associated to CAR T cell therapy and needs to be considered as a rare potential complication.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240064 | PMC |
| http://dx.doi.org/10.3389/fonc.2023.1149450 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring intimacy and family planning in Inflammatory Bowel Diseases: a qualitative study.
Ann Med
December 2024
Olomouc University Social Health Institute, Univerzita Palackeho v Olomouci, Olomouc, Czech Republic.
Background: Inflammatory bowel diseases (IBD), comprising ulcerative colitis and Crohn's disease, have a profound impact on people's lives. This study aims to investigate the perceived impact of IBD on sexual life and family planning to enhance understanding of the interplay between IBD, sexuality, intimacy and family planning to foster a better quality of life for those living with the condition.
Materials And Methods: The study used the qualitative DIPEx method (Database of Personal Experiences of Health and Illness) developed by the Health Experiences Research Group at the University of Oxford, standardized for the Czech Republic.
Identification of endoplasmic reticulum stress-associated genes and subtypes for predicting risk signature and depicting immune features in inflammatory bowel disease.
Heliyon
September 2024
Department of Pathology, Xiangya Hospital, Central South University, Changsha City, Hunan Province, China.
Article Synopsis
- Endoplasmic reticulum stress (ERS) plays a crucial role in inflammatory bowel disease (IBD) and the research aimed to identify molecular markers related to ERS and inflammation, focusing on risk factors and high-risk patient groups.
- Using statistical methods like LASSO and logistic regression, the study created a predictive model that categorized IBD patients and discovered four gene clusters, revealing significant differences in gene expression and immune functions between high-risk and low-risk groups.
- A key gene was identified as a strong predictor for IBD with potential as a diagnostic marker and therapeutic target, highlighting the need for personalized therapy based on the new ERS-associated gene model in IBD management.
Clinicopathologic Features of Primary Immunodeficiency Monogenic Disease-related Very Early Onset Inflammatory Bowel Disease: Focus on Gastrointestinal Histologic Features in IFIH1 Mutations.
Adv Anat Pathol
August 2024
Pathology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini, San Giovanni Rotondo (FG), Italy.
Very early onset inflammatory bowel disease (VEO-IBD) is a clinical term referring to IBD-like symptomatology arising in children younger than 6 years. VEO-IBD may be due to polygenic etiology in "pure" IBD (Crohn disease-CD and ulcerative colitis-UC), or it may be caused by primary immunodeficiency underlined by monogenic disease. Primary immunodeficiency monogenic diseases have a Mendelian inheritance and affect the immune system with multiorgan morbidity and possible effects on the gastrointestinal system.
View Article and Find Full Text PDFGastrointestinal system involvement in patients with primary immunodeficiency: a single center experience.
Scand J Gastroenterol
September 2024
Selcuk University Medical Faculty, Pediatric Immunology and Allergy, Konya, Turkey.
Aim: Primary immunodeficiencies (PIDs) are a heterogeneous disorder group characterized by an impaired immune system, leading to an increased susceptibility to infections and a wide range of clinical manifestations, including gastrointestinal (GI) complications. This study aimed to assess the GI manifestations of PID patients and highlight the significance of atypical gastrointestinal symptoms in the early diagnosis of these patients.
Methods: A retrospective analysis was conducted on pediatric patients diagnosed with PIDs at Selcuk University Medical Faculty from 2011 to 2021.
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.
ESMO Open
July 2024
Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address:
Background: Data regarding the clinical outcome of patients with immune checkpoint inhibitor (ICI)-induced colitis are scant. We aimed to describe the 12-month clinical outcome of patients with ICI-induced colitis.
Materials And Methods: This was a retrospective, European, multicentre study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!